Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02566850 · ClinicalTrials.gov registry record · NA
Investigational Study of the Ekso for High-Dosage Use by Individuals With SCI in a Non-Clinical Environment
A NA study, sponsored by Ekso Bionics.
- Terminated
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT02566850 is a NA study that was terminated before completion, run by Ekso Bionics. The registered enrollment target is 4 participants.
The verdict
NCT02566850, a NA study, was terminated before completion, sponsored by Ekso Bionics.
- TERMINATED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
The purpose of the study is to study the safety and health effects of using the Ekso Bionics powered exoskeleton device in a home setting over an extended period, ranging from 12-42 months.
Interventions
- DEVICE Ekso
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2014-01 |
| Est. Completion | 2017-07-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02566850
The ClinicalTrials.gov registry entry for NCT02566850 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ekso Bionics, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ekso is the first listed.
NCT02566850 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02566850 about?
NCT02566850 is a clinical study titled "Investigational Study of the Ekso for High-Dosage Use by Individuals With SCI in a Non-Clinical Environment". The purpose of the study is to study the safety and health effects of using the Ekso Bionics powered exoskeleton device in a home setting over an extended period, ranging from 12-42 months.
What is the current status of trial NCT02566850?
This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2014-01. Estimated completion is 2017-07-25.
What interventions are being tested in trial NCT02566850?
The interventions under investigation include: Ekso (DEVICE).
Who is sponsoring clinical trial NCT02566850?
This trial is sponsored by Ekso Bionics, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.